IL146815A0 - Method for treating chronic obstructive pulmonary disease - Google Patents

Method for treating chronic obstructive pulmonary disease

Info

Publication number
IL146815A0
IL146815A0 IL14681501A IL14681501A IL146815A0 IL 146815 A0 IL146815 A0 IL 146815A0 IL 14681501 A IL14681501 A IL 14681501A IL 14681501 A IL14681501 A IL 14681501A IL 146815 A0 IL146815 A0 IL 146815A0
Authority
IL
Israel
Prior art keywords
pulmonary disease
chronic obstructive
obstructive pulmonary
treating chronic
treating
Prior art date
Application number
IL14681501A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL146815A0 publication Critical patent/IL146815A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14681501A 2000-12-07 2001-11-29 Method for treating chronic obstructive pulmonary disease IL146815A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25199800P 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
IL146815A0 true IL146815A0 (en) 2002-07-25

Family

ID=22954231

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14681501A IL146815A0 (en) 2000-12-07 2001-11-29 Method for treating chronic obstructive pulmonary disease

Country Status (10)

Country Link
US (1) US20020115661A1 (fr)
EP (1) EP1213019A3 (fr)
JP (1) JP2002326957A (fr)
KR (1) KR20020045552A (fr)
AU (1) AU9703601A (fr)
CA (1) CA2360127A1 (fr)
HU (1) HUP0105267A2 (fr)
IL (1) IL146815A0 (fr)
NZ (1) NZ515513A (fr)
ZA (1) ZA200110080B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007261962A (ja) * 2006-03-27 2007-10-11 Oita Univ 肺高血圧症に有用なエンドセリン受容体拮抗薬。

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US6265399B1 (en) * 1997-09-05 2001-07-24 Warner-Lambert Company Certain benzothiazine dioxide endothelin antagonists and processes for their preparation

Also Published As

Publication number Publication date
JP2002326957A (ja) 2002-11-15
HUP0105267A2 (en) 2002-08-28
EP1213019A2 (fr) 2002-06-12
NZ515513A (en) 2003-05-30
US20020115661A1 (en) 2002-08-22
KR20020045552A (ko) 2002-06-19
CA2360127A1 (fr) 2002-06-07
ZA200110080B (en) 2003-07-30
HU0105267D0 (en) 2002-02-28
AU9703601A (en) 2002-06-13
EP1213019A3 (fr) 2004-12-29

Similar Documents

Publication Publication Date Title
AU2001275974A1 (en) Method for treating chronic obstructive pulmonary disorder
EP1494711A4 (fr) Procedes de traitement de la broncho-pneumopathie chronique obstructive (bpco)
IL173987A0 (en) Mucoactive agents for treating a pulmonary disease
AU7692601A (en) Method for treating multiple wellbore intervals
EP1261370A4 (fr) Methode therapeutique destinee a reduire l'angiogenese
IL152511A0 (en) Apparatus and methods for treating congestive heart disease
AU2001238472A1 (en) Method for treating parathyroid disorders
AU8298801A (en) Methods for treating atopic disorders
EP1304337A4 (fr) Procede de formation de cellulose
HUP0401805A3 (en) Compounds suitable for treating pulmonary diseases
SG94803A1 (en) Adaptive off-track recovery
IL143636A0 (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
MXPA03006607A (es) Metodo combinado para tratar trastornos dependientes de hormonas.
PL361146A1 (en) Method for producing isocyanato-organosilanes
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
AU2472701A (en) A method of treating a systemic disease
EP1273611A4 (fr) Procede de production de polyimide
IL146815A0 (en) Method for treating chronic obstructive pulmonary disease
HK1038703A1 (zh) 糖皮質類固醇在制備治療輕度/早期copd(慢性阻塞性肺病)的藥物中的應用
IL145799A0 (en) Method for treating neurodegeneration
GB0026838D0 (en) Treatment method
EP1359910A4 (fr) Procede relatif au traitement du glaucome ii b
AU7265900A (en) Method for producing otoplastics
AU8850301A (en) Apparatus for treatment of chronic obstructive pulmonary disease and associated method
HK1051861A1 (en) Method for producing 5-aryl nicotinaldehydes